Detailed Program
Tuesday, March 12, 2024
12:00 p.m. - 6:00 p.m. |
Registration |
Lobby |
|
1:00 p.m. - 5:00 p.m. |
Meeting Room 1 |
||
5:30 p.m. - 7:00 p.m. |
Mentor in a Cloud |
South Foyer |
Wednesday, March 13, 2024
7:00 a.m. - 6:00 p.m. |
Registration |
Lobby |
|
8:30 a.m. - 5:00 p.m. |
Satellites |
|
|
Meeting Room 1 |
|||
Meeting Room 8&15 |
|||
Meeting Room 2&3 |
|||
Meeting Room 11 |
|||
12:00 p.m. - 1:00 p.m. |
Mid-Career Session |
Meeting Room 12 |
|
5:15 p.m. - 6:15 p.m. |
Early Career Forum |
Meeting Room 2&3 |
|
6:30 p.m. - 8:00 p.m. |
Welcome Reception |
Ballroom BC |
Thursday, March 14, 2024
7:00 a.m. - 6:00 p.m. |
Registration |
Lobby |
||
8:00 a.m. - 8:10 a.m. |
Presidential Welcome |
Ballroom BC |
||
8:10 a.m. - 9:00 a.m. |
President's Distinguished Lecture I Prof. Tessa Roseboom, PhD Laying foundation for healthy generations: lessons from the past to inform the future |
Ballroom BC |
||
9:00 a.m. - 10:00 a.m. |
President's New Investigator Plenary |
Ballroom BC |
||
9:00 a.m. - 9:15 a.m. |
O-001: Maternal Extracellular Vesicle Derived miR-375-3p Promotes Fetal Overgrowth in Healthy Pregnant Mice |
|||
9:15 a.m. - 9:30 a.m. |
O-002: Modulating an Essential Gene for Cellular Senescence in a Mouse Model of Pelvic Organ Prolapse |
|||
9:30 a.m. - 9:45 a.m. |
O-003: In Utero Endothelial Cells Under-Express Vasculature Development Genes and Have Poor Elongation in Response to Flow in Single Ventricle Congenital Heart Disease |
|||
9:45 a.m. - 10:00 a.m. |
O-004: Human Vaginal Stem Cells: Identification Using Cell Surface Markers and Functional Assays |
|||
10:00 a.m. - 12:00 p.m. |
Poster Session I |
Exhibit Hall B |
||
12:00 p.m. - 1:00 p.m. |
Lunch & Learn Session Moderators: Pregnancy and newborn health in Africa: A research perspective AMPATH: A collaboration to improve reproductive health in Western Kenya |
Ballroom BC |
||
1:15 p.m. - 3:15 p.m. |
Concurrent Mini-Symposia I |
|
||
Interventions to Support Healthy Life Trajectories in Humans Moderators: |
Meeting Room 11 |
|||
1:15 p.m. - 1:45 p.m. |
Revolutionising maternal and newborn care in Africa: Pathways for a healthier future |
|
||
1:45 p.m. - 2:15 p.m. |
Designing Digital Interventions to reduce Lifecourse Risk among Patients with Polycystic Ovary Syndrome (PCOS) |
|||
2:15 p.m. - 2:45 p.m. |
Maternal Obesity; Consequences for Cardiac Function in the Child |
|||
2:45 p.m. - 3:15 p.m. |
Maternal metabolic and mental health and offspring health and development – translation of research findings into interventions and policy. |
|||
Brain Health Across the Lifespan: Effects of Adverse Pregnancy |
Meeting Room 8/15 |
|||
Moderators: |
||||
1:15 p.m. - 1:45 p.m. |
Fetal cerebrovascular implication of fetal growth restriction |
|||
1:45 p.m. - 2:15 p.m. |
Therapeutic targets for perinatal brain injury |
|||
2:15 p.m. - 2:45 p.m. |
The impact of obesity in pregnancy on offspring hypothalamic feeding pathways |
|||
2:45 p.m. - 3:15 p.m. |
Maternal brain risk in adverse pregnancy |
|||
Don't Forget Mum! - Adverse Pregnancy and Maternal Health Risk |
Meeting Room 2/3 Meeting Level - East |
|||
Moderators: Sandra Davidge, PhD, FCAHS, FRSC Shawn Chavez, PhD |
||||
1:15 p.m. - 1:45 p.m. |
Interventions during obese pregnancy: opportunities to improve maternal as well as offspring health |
|||
1:45 p.m. - 2:15 p.m. |
Mechanisms for impaired cardiovascular outcomes following preeclampsia - evidence from animal studies |
|||
2:15 p.m. - 2:45 p.m. |
GDM precision prevention, diagnosis, prognosis, and treatment: The EMPOWeR trial |
|||
2:45 p.m. - 3:15 p.m. |
Maternal cardiometabolic health following pregnancy complications in women living with socioeconomic disadvantage |
|||
Next Generation Biomaterials for Reproductive Research Moderators: |
Meeting Room 1 |
|||
1:15 p.m. - 1:45 p.m. |
Targeted Nanoliposome Therapy in Obstetrics and Gynecology |
|||
1:45 p.m. - 2:15 p.m. |
Menstrual fluid for the study of endometrial biology |
|||
2:15 p.m. - 2:45 p.m. |
Tissue engineering the endometriotic phenotype using organoid systems |
|||
2:45 p.m. - 3:15 p.m. |
Decidua-mimicking hydrogels for the study of trophoblast invasion |
|||
Environmental toxins and Uterine Fibroids Moderators: |
Meeting Room 12 Meeting Level - East |
|||
1:15 p.m. - 1:45 p.m. |
Effects of endocrine-disrupting chemicals on female reproductive health |
|||
1:45 p.m. - 2:15 p.m. |
At-risk myometrial stem cells response to phthalate exposures using a novel 3D organoid model |
|||
2:15 p.m. - 2:45 p.m. |
Phthalates and leiomyoma pathogenesis: Molecular mechanisms |
|||
2:45 p.m. - 3:15 p.m. |
Phthalates and uterine fibroids: A public health perspective |
|||
Nanotubes in Reproduction Moderators: |
Meeting Room 13 |
|||
1:15 p.m. - 1:45 p.m. |
Introduction and State-of-the-Field of Tunneling Nanotubes (TNTs) and Related Cell Protrusions: an overview of their potential functions and implications |
|||
1:45 p.m. - 2:15 p.m. |
Cellular networking via tunneling nanotubes in ovarian cancer |
|||
2:15 p.m. - 2:45 p.m. |
Tunneling nanotubes: Macrophage-Myocyte communication and cargo transport in pregnant uterus |
|||
2:45 p.m. - 3:15 p.m. |
Intercellular Communication in the Ovarian Follicle: Strategies and Tools |
|||
3:15 p.m. - 3:30 p.m. |
Coffee Break |
|
||
3:30 p.m. - 5:30 p.m. |
Concurrent Oral Presentations I |
|
||
Clinical and Translational Perinatology I Moderators: |
Meeting Room 1 |
|||
3:30 p.m. - 3:45 p.m. |
O-005: The Associations between Diet and Cardiometabolic Health After Pregnancy |
|||
3:45 p.m. - 4:00 p.m. |
O-006: Development of an Explainable AI Tool for Risk Stratification in Fetal Growth Restriction |
|||
4:00 p.m. - 4:15 p.m. |
O-007: Maternal Body Mass Index and Neonatal Morbidity After Labor at Term |
|||
4:15 p.m. - 4:30 p.m. |
O-008: Childhood Sexual Abuse and Post Cesarean Pain |
|||
4:30 p.m. - 4:45 p.m. |
O-009: Changes in Sphingolipid Content of Small Extracellular Vesicles from Gestational Diabetes Pregnancies Contribute to Maternal Endothelial Dysfunction |
|||
4:45 p.m. - 5:00 p.m. |
O-012: Maternal Hyperinsulinemia Independently Alters Immune Cell Composition and Induces Placental Inflammation |
|||
5:00 p.m. - 5:15 p.m. |
O-011: Maternal DHA Supplementation Alters Placental Phospholipid Content |
|||
5:15 p.m. - 5:30 p.m. |
O-010: Maternal Diet Determines Offspring Gut Serotonin Response in Primates |
|||
Gynecology I Moderators: |
Meeting Room 2/3 Meeting Level - East |
|||
3:30 p.m. - 3:45 p.m. |
O-013: Using Cancer-Driver Mutations to Identify Candidate Drug Targets for Endometriosis Therapy |
|||
3:45 p.m. - 4:00 p.m. |
O-014: Endometriotic Epithelium Activates Inflammatory Signaling of Macrophages in Superficial Peritoneal Lesions |
|||
4:00 p.m. - 4:15 p.m. |
O-015:The Biophysical Microenvironment Impacts Endometrial Epithelial Tissue Invasion |
|||
4:15 p.m. - 4:30 p.m. |
O-016: Reversal of Fibrosis with Improvement of Endometrial Receptivity of Adenomyotic Uteri by Conditioned Media of Adipose-Derived Stem Cells |
|||
4:30 p.m. - 4:45 p.m. |
O-017: Therapeutic Effect of Nanoceria as a Non-Steroidal Anti-Inflammatory Drug on Endometriosis in a Mouse Model |
|||
4:45 p.m. - 5:00 p.m. |
O-018: Impaired Bone Morphogenetic Protein Signaling Pathways Disrupt Decidualization in Endometriosis |
|||
5:00 p.m. - 5:15 p.m. |
O-019: Higher Prevalence of Somatic Cancer Driver Mutations in Deeply Invasive Endometriosis and Endometriomas Compared to Superficial Endometriosis |
|||
5:15 p.m. - 5:30 p.m. |
O-020: SPIRIT Long-Term Extension Study: Subgroup Analyses of Dysmenorrhea and Non-Menstrual Pelvic Pain Response through 104 Weeks |
|||
Parturition I Moderators: |
Meeting Room 8/15 |
|||
3:30 p.m. - 3:45 p.m. |
O-021: Inflammation-Associated Preterm Labor via Progesterone Withdrawal in Decidual Stromal Cells |
|||
3:45 p.m. - 4:00 p.m. |
O-022: HLA-G: A Frontline Immunomodulator at the Chorio-Decidual Interface |
|||
4:00 p.m. - 4:15 p.m. |
O-023: Maximal Delay to Administer HSJ633, an Allosteric Anti-IL-6R, After Inducing Preterm Labor to Prevent Preterm Birth and Adverse Neonatal Outcomes |
|||
4:15 p.m. - 4:30 p.m. |
O-024: Whole Cervix Imaging of Collagen, Muscle, and Cellularity in Term and Preterm Patient |
|||
4:30 p.m. - 4:45 p.m. |
O-025: Circulating Levels of miRNA Biomarkers Measured at 12 Weeks Predict Subsequent Fetal Growth Restriction and Preterm Birth |
|||
4:45 p.m. - 5:00 p.m. |
O-026: Phosphorylation of ERK via Hyaluronan Signaling Regulates the Barrier Mechanism at Cervical Epithelium |
|||
5:00 p.m. - 5:15 p.m. |
O-027: Effect of Ephedrine, Phenylephrine, and Norepinephrine on Myometrial Contractility |
|||
5:15 p.m. - 5:30 p.m. |
O-028: Fetal Intramuscular Administration of Rytvela Partially Resolved LPS-Induced Inflammation in Preterm Sheep |
|||
Placenta I Moderators: |
Meeting Room 11 |
|||
3:30 p.m. - 3:45 p.m. |
O-029: Lessons Learned in Single-Cell vs. Single-Nuclei RNA-Sequencing of the Placenta in Health and Disease |
|||
3:45 p.m. - 4:00 p.m. |
O-030: Improving Analysis and Interpretation of Single-Cell Sequencing Approaches |
|||
4:00 p.m. - 4:15 p.m. |
O-031: Mid-late Gestation Leptin Infusion Induces Placental Mitochondrial and Endoplasmic Reticulum Unfolded Protein Responses in a Mouse Model of Preeclampsia |
|||
4:15 p.m. - 4:30 p.m. |
O-032: The Epigenetic Factor PHF13 Governs Trophoblast Stemness and Differentiation |
|||
4:30 p.m. - 4:45 p.m. |
O-033: Mitigation of Placental Insufficiency and Fetal Growth Restriction through IGF1 Gene Therapy in a Guinea Pig Model |
|||
4:45 p.m. - 5:00 p.m. |
O-034: Multiomics Analysis of Placental Dysfunction in Obstetric Disorders |
|||
5:00 p.m. - 5:15 p.m. |
O-035: SINE RNA in Imprinted microRNA Clusters: A Key Player in Placental Intrinsic Defense Against Various Pathogens |
|||
5:15 p.m. - 5:30 p.m. |
O-036: Macrophage Polarization and Function at the Maternal-Fetal Interface is Both Pro- and Anti-Inflammatory in the Setting of Intrauterine Infection |
|||
Maternal Health & Biology Moderators: |
Meeting Room 12 |
|||
3:30 p.m. - 3:45 p.m. |
O-037: Influenza A Virus Disease Severity and Pathogenesis in a Pregnant Non-Human Primate Model |
|||
3:45 p.m. - 4:00 p.m. |
O-038: Preeclampsia Attenuates Middle Cerebral Artery Resistance Post-Pregnancy in the Setting of Sustained Hypertension |
|||
4:00 p.m. - 4:15 p.m. |
O-039: Identification of Unique Epithelia Lineage Specification Patterns in the Cervix during Pregnancy |
|||
4:15 p.m. - 4:30 p.m. |
O-040: Maternal Obesity Impacts Enterobacteriaceae Strains in Human Newborns That Increase TMAO and Provoke Hepatic Fibrosis in Adulthood |
|||
4:30 p.m. - 4:45 p.m. |
O-041: Reduced Maternal Cardiac Output in Pregnancies Complicated by Placental Insufficiency May Not Be Due to Lower Fetal Weight as Measured by Cardiovascular MRI in Sheep |
|||
4:45 p.m. - 5:00 p.m. |
O-042: Maternal Obesity Dampens Changes in Metabolic Flexibility across Gestation |
|||
5:00 p.m. - 5:15 p.m. |
O-043: PFAS Exposures During Pregnancy and Midlife Cardiovascular Disease Risk Factors in Women of the Project Viva Cohort |
|||
5:15 p.m. - 5:30 p.m. |
O-044: Periconceptional Obesity and Diet Independently Change the Gut Microbiota in Pregnant Mice and Alter Maternal Immune Responses and Pregnancy Outcome |
|||
Reproductive Biology I Moderators: |
Meeting Room 13 |
|||
3:30 p.m. - 3:45 p.m. |
O-045: Unravelling the Role of Thrombospondin-1 (THBS1) in the Ovary: Reproductive Characterization of a THBS1 Knockout Mouse Model |
|||
3:45 p.m. - 4:00 p.m. |
O-156: Effects of Superovulation on Ovarian Perifollicular Angiogenesis |
|||
4:00 p.m. - 4:15 p.m. |
O-046: Temporal Transcriptomic Profiles Suggest p53-Mediated Apoptotic Pathway is Involved in Cyclophosphamide Treated Mouse Ovaries |
|||
4:15 p.m. - 4:30 p.m. |
O-047: Lowering Insulin Alleviates Age- and Diet-Induced Reproductive Dysfunction in Female Mice |
|||
4:30 p.m. - 4:45 p.m. |
O-157: Obesity Induced Disruption Of The Murine Gut Microbiota Impairs Ovarian Function |
|||
4:45 p.m. - 5:00 p.m. |
O-048: Growth Factor-Enriched Xenogeneic Ovarian ECM Hydrogels: A Promising Treatment for Premature Ovarian Failure |
|||
5:00 p.m. - 5:15 p.m. |
O-049: Engineering Synthetic Hydrogels for Modeling Vascularized Endometriosis Lesions in Microfluidic Devices |
|||
5:15 p.m. - 5:30 p.m. |
O-158: Stromal Progesterone Receptor is Crucial for Establishing Mouse Uterine Receptivity and Decidual Response |
|||
5:45 p.m. - 7:15 p.m. |
Connection Corners |
East Ballroom A |
Friday, March 15, 2024
7:00 a.m. - 6:00 p.m. |
Registration |
Lobby |
|
8:00 a.m. - 8:10 a.m. |
Presidential Welcome |
Ballroom BC |
|
8:10 a.m. - 9:00 a.m. |
President's Distinguished Lecture II Tracy Bale, PhD |
Ballroom BC |
|
9:00 a.m. - 11:00 a.m. |
Poster Session II |
Exhibit Hall B |
|
11:00 a.m. - 12:30 p.m. |
Concurrent Oral Presentations II |
|
|
Developmental Programming I Moderators: |
Meeting Room 1 |
||
11:00 a.m. - 11:15 a.m. |
O-050: Breaking Rules: The Complex Relationship between DNA Methylation and X-Chromosome Inactivation in the Human Placenta |
||
11:15 a.m. - 11:30 a.m. |
O-051: Bioaccumulation of Microplastics in Placentae Associated with Environmental Chemical Exposures and Obstetrical Outcomes |
||
11:30 a.m. - 11:45 a.m. |
O-052: Biomarkers of Chronic Stress in Association with Maternal ‘Vulnerability’ and the Impact on Embryonic Growth: The Rotterdam Periconceptional Cohort (Predict Study) |
||
11:45 a.m. - 12:00 p.m. |
O-053: Periconceptual CoQ10 Effects on Reproductive and Perinatal Consequences from Maternal Dyslipidemia |
||
12:00 p.m. - 12:15 p.m. |
O-054: Periconceptional Stress Signalling through O-GlcNAcylation: Effects on Placental Development |
||
12:15 p.m. - 12:30 p.m. |
O-055: Conserved DNA Methylation Signatures in Neonatal Blood of Humans and Guinea Pigs Exposed to Antenatal Corticosteroid Treatment |
||
Fetus I Moderators: |
Meeting Room 2/3 |
||
11:00 a.m. - 11:15 a.m. |
O-056: Decoding the Mystery of Recurrent Pregnancy Loss: Revelations from Genome Sequencing |
||
11:15 a.m. - 11:30 a.m. |
O-057: Early Origins of Cardiac Dysfunction in an Embryonic Model of Obstructive Sleep Apnea During Development |
||
11:30 a.m. - 11:45 a.m. |
O-058: Replacement Insulin during IGF-1 Infusion Increases Body Growth and Myoblast Proliferation in Fetal Sheep |
||
11:45 a.m. - 12:00 p.m. |
O-059: Testing a Genetic Risk Score for Birth Weight for Generalizability Across Races |
||
12:00 p.m. - 12:15 p.m. |
O-060: Astrocytes Modulate Drug Transporter Activity in Human Fetal Brain Endothelial Cells |
||
12:15 p.m. - 12:30 p.m. |
O-061: The Extremely Preterm Ovine Fetus Lacks the Ability to Compensate for Loss of Placental Growth Factor Input When Undergoing Artificial Placenta Treatment |
||
Preeclampsia I Moderators: |
Meeting Room 8/15 |
||
11:00 a.m. - 11:15 a.m. |
O-062: Placenta-Derived Small Extracellular Vesicles Impair Maternal Endothelial Function via Ceramide-Induced Mitochondrial Fission in Early-Onset Preeclampsia |
||
11:15 a.m. - 11:30 a.m. |
O-063: Extracellular Mitochondrial DNA Impairs Maternal Endothelial Function in Rat Aorta during Pregnancy |
||
11:30 a.m. - 11:45 a.m. |
O-064: Single-Cell Analysis of Preeclampsia with and without IUGR: Placental Insights |
||
11:45 a.m. - 12:00 p.m. |
O-065: Anti-Ferroptotic Drugs as a Novel Tool to Reduce Placental sFlt-1 Secretion: A Potential Treatment for Preeclampsia |
||
12:00 p.m. - 12:15 p.m. |
O-066: LOX-1 Inhibition Selectively Prevents Aortic but Not Cerebral Stiffness in a Model of Preeclampsia |
||
12:15 p.m. - 12:30 p.m. |
O-067: The Cardioselective Beta-1 Blockers, Bisoprolol and Nebivolol, Affect Fetoplacental Vascular Function |
||
Gynecology II Moderators: |
Meeting Room 11 |
||
11:00 a.m. - 11:15 a.m. |
O-068: Coenzyme Q-10 Reduces the Aberrant Production of Extracellular Matrix Proteins in Uterine Leiomyomas through Its Effect on the Transforming Growth Factor Beta 3 Pathway |
||
11:15 a.m. - 11:30 a.m. |
O-069: Phthalate Metabolite Exposure Induces Accumulation of Oxidative Stress and Extracellular Matrix in Pre-Fibroid Myometrial Stem Cell-Derived 3D Organoids: Modeling a Fibroid Phenotype |
||
11:30 a.m. - 11:45 a.m. |
O-070: E-proteins Regulates Estrogen Signaling and Immune Function during Endometriotic Lesion Development |
||
11:45 a.m. - 12:00 p.m. |
O-071: Potential for Diagnosis of Endometriosis Using 99mTc-Maraciclatide |
||
12:00 p.m. - 12:15 p.m. |
O-072: Simvastatin and Mifepristone Act Synergistically to Inhibits PR-A/B Signaling in Uterine Leiomyomas |
||
12:15 p.m. - 12:30 p.m. |
O-073: Differential Expression of Race and MED12-Associated Long Non-Coding RNAs in Uterine Leiomyomas |
||
Parturition II Moderators: |
Meeting Room 12 |
||
11:00 a.m. - 11:15 a.m. |
O-074: Mapping Changes in Uterine Contractility during the Ovulatory Cycle with Wide-Area Calcium Imaging in Live Mice |
||
11:15 a.m. - 11:30 a.m. |
O-075: Noninvasive Uterine Maturation Biomarkers Modeled through Electromyometrial Imaging and Spike Propagation Graph Analysis |
||
11:30 a.m. - 11:45 a.m. |
O-076: The Opioid Buprenorphine Induces Fetal Membrane Sterile Inflammation in Part through Toll-Like Receptor 4 Activation |
||
11:45 a.m. - 12:00 p.m. |
O-077: Vaginal Administration of Live Biotherapeutic Lactobacillus Crispatus CTV-05 in Pregnancy Leads to Persistent Colonisation and Reduces Inflammation |
||
12:00 p.m. - 12:15 p.m. |
O-078: Tissue-Specific Fetal Brain and Membrane Inflammasome Activation by Choriodecidual Ureaplasma parvum Infection in a Rhesus Macaque Model |
||
12:15 p.m. - 12:30 p.m. |
O-079: Cervical Epigenome Profiling Early in Pregnancy for Insight into Perinatal Outcomes |
||
Reproductive Endocrinology and Infertility I Moderators: |
Meeting Room 13 |
||
11:00 a.m. - 11:15 a.m. |
O-080: Correlation between Uterine Fluid Leukocytes at the Time of Frozen Embryo Transfer and Pregnancy Outcomes |
||
11:15 a.m. - 11:30 a.m. |
O-081: Testis-Specific Exosomes Protect Testicular Damage through p38MAPK/ERK and AKT Signaling Pathways in Prepubescent Mice: A Paradigm Shift in Fertility Preservation |
||
11:30 a.m. - 11:45 a.m. |
O-082: Peak Endometrial Thickness is Not Predictive of Live Birth Rate in Patients Undergoing Frozen Embryo Transfer |
||
11:45 a.m. - 12:00 p.m. |
O-083: Endometrial Host-Microbiome Interactions through Immune Defense Mechanism and GPCR Signaling in Reproductive Health |
||
12:00 p.m. - 12:15 p.m. |
O-084: Assisted Reproductive Technology (ART) Pregnancies Display an Increase in Placentation Abnormalities Compared to Unassisted Pregnancies or Pregnancies from Non-IVF Fertility Treatment (NIFT) in Patients with Sub/Infertility |
||
12:15 p.m. - 12:30 p.m. |
O-085: Alya Purple: Patient-Specific Multi-Scale, Multi-Physics Simulations of Human Uterine Contractions and Peristalsis during Pregnancy and the Menstrual Cycle |
||
12:30 p.m. - 1:30 p.m. |
Diversity, Equity & Inclusion Forum: Addressing Health Equity Across Geographic and Reproductive Health Perspectives Moderators: The 2024 DEI Forum will consist of a panel of diverse experts including: Bo Jacobsson, MD, PhD |
Ballroom BC |
|
1:45 p.m. - 3:45 p.m. |
Concurrent Mini-Symposia II |
|
|
Circadian Rhythmicity and Lifelong Health Moderators: |
Meeting Room 13 |
||
1:45 p.m. - 2:15 p.m. |
Circadian rhythms in the placenta |
||
2:15 p.m. - 2:45 p.m. |
Perinatal time cues and potential acute and long-term health effects |
||
2:45 p.m. - 3:15 p.m. |
Timing and Pregnancy Outcomes |
||
3:15 p.m. - 3:45 p.m. |
Sexual dimorphism and imprinting in circadian entrainment of metabolism and behavior |
||
The Mighty Mitochondrion: Cell Powerhouse and Beyond Moderators: |
Meeting Room 11 |
||
1:45 p.m. - 2:15 p.m. |
Circulating cell-free mitochondrial DNA in preeclampsia: pathogenic trigger or marker of stress? |
||
2:15 p.m. - 2:45 p.m. |
Small but powerful messengers: The contribution of placental small extracellular vesicles to maternal mitochondrial homeostasis in preeclampsia |
||
2:45 p.m. - 3:15 p.m. |
Oocyte mitochondria: Key regulators of oocyte and ovary development |
||
3:15 p.m. - 3:45 p.m. |
Oocyte mtDNA supplementation and developmental outcome |
||
Don't Forget Dad! - Paternal Influence on Disease Programming Moderators: |
Meeting Room 2&3 |
||
1:45 p.m. - 2:15 p.m. |
Understanding the ‘sperm RNA code’ for epigenetic inheritance with emerging tools |
||
2:15 p.m. - 2:45 p.m. |
Glucocorticoids, the Epididymis and Transgenerational Transmission |
||
2:45 p.m. - 3:15 p.m. |
tRNA fragments – transferring information between generations |
||
3:15 p.m. - 3:45 p.m. |
Intergenerational inheritance of obesity and hepatic steatosis: The role of germline microRNAs |
||
Cutting Edge Technologies in Reproduction Moderators: |
Meeting Room 8/15 |
||
1:45 p.m. - 2:15 p.m. |
Single-cell genomics in reproduction and development |
||
2:15 p.m. - 2:45 p.m. |
Single cell genomics and ovarian function and dysfunction |
||
2:45 p.m. - 3:15 p.m. |
Navigating PCOS Complexities through Cutting-Edge Methods and Technologies |
||
3:15 p.m. - 3:45 p.m. |
Synthetic Ex Utero Embryogenesis:from Naive Stem Cells to Complete Embryo Models |
||
Artificial Intelligence in Reproductive Sciences Moderators: |
Meeting Room 1 |
||
1:45 p.m. - 2:15 p.m. |
Application of Artificial Intelligence in the IVF Laboratory |
||
2:15 p.m. - 2:45 p.m. |
Decoding Preeclampsia: AI Technologies to Predict Maternal Risk |
||
2:45 p.m. - 3:15 p.m. |
The power and pitfalls of AI in global reproductive health |
||
3:15 p.m. - 3:45 p.m. |
AI-based tools for prediction of myometrial tumors |
||
Advanced Imaging: Connecting Biophysics with Reproduction Moderators: |
Meeting Room 12 |
||
1:45 p.m. - 2:15 p.m. |
Prenatal Diagnosis of Human Placental Diseases: integration of imaging methods and Placenta Growth Factor (PlGF) |
||
2:15 p.m. - 2:45 p.m. |
High intensity focused ultrasound (HIFU) for twin-twin transfusion syndrome: challenges and successes |
||
2:45 p.m. - 3:15 p.m. |
Placental and fetal MRI in detecting fetal growth restriction |
||
3:15 p.m. - 3:45 p.m. |
Enhancing Endometriosis Imaging to Enhance Clinical and Surgical Care |
||
3:45 p.m. - 4:00 p.m. |
Coffee Break |
Meeting Level - East |
|
4:00 p.m. - 5:30 p.m. |
Concurrent Oral Presentations III |
|
|
Global Population Health Moderators: |
Meeting Room 1 |
||
4:00 p.m. - 4:15 p.m. |
O-086: Preconception Paternal Adherence to a Prudent Diet Pattern: A Shield Against Accelerated Child Growth |
||
4:15 p.m. - 4:30 p.m. |
O-087: Use of Antiviral Medication during Pregnancy Reduces the Risk of Preeclampsia |
||
4:30 p.m. - 4:45 p.m. |
O-088: Association between Neighborhood Poverty and Pregestational Comorbidities in a Birthing Population from a Segregated Region |
||
4:45 p.m. - 5:00 p.m. |
O-089: Prenatal Antidepressant Exposure and Long-Term Child Development: A Population-Based Cohort Study |
||
5:00 p.m. - 5:15 p.m. |
O-090: Reframing the Economic Arguments for Improving Obstetrical Care: Saving Money Costs Too Much |
||
5:15 p.m. - 5:30 p.m. |
O-091: The Economic Burden of Uterine Fibroids in the United States 2022: A Comparative Cost-Analysis |
||
Developmental Programming II Moderators: |
Meeting Room 2/3 |
||
4:00 p.m. - 4:15 p.m. |
O-092: Maternal Obesity Causes Cardiac Contractile Dysfunction in Mouse Fetuses In Utero |
||
4:15 p.m. - 4:30 p.m. |
O-093: iR-21-5p Protects Embryos Against Developmental Hypoxia-Induced Cardiac Dysfunction |
||
4:30 p.m. - 4:45 p.m. |
O-094: Maternal High-Fat Diet Affects Lung Function in the Newly Weaned Offspring |
||
4:45 p.m. - 5:00 p.m. |
O-095: Beyond Birthweight: Unravelling the Roles of Genetics and Early Life Nutrition in Mitigating Child Obesity |
||
5:00 p.m. - 5:15 p.m. |
O-096: Chronic Prenatal Delta-9-Tetrahydrocannabinol Exposure Impacts Offspring Neurodevelopment and Emotional Behavior |
||
5:15 p.m. - 5:30 p.m. |
O-097: Silencing Neuroinflammatory Reactive Astrocyte Activating Factors Ameliorates Disease Outcomes in Perinatal White Matter Injury |
||
Reproductive Biology II Moderators: |
Meeting Room 8/15 |
||
4:00 p.m. - 4:15 p.m. |
O-098: Development and Characterization of a 3D Human Endometrium-on-a-Chip Model |
||
4:15 p.m. - 4:30 p.m. |
O-099: Establishment of In Vitro Implantation Model Using Newly Developed Endometrial Organoid |
||
4:30 p.m. - 4:45 p.m. |
O-100: 3D In Vitro Modelling of Embryo-Endometrial Interface Unravels Entosis Role on Cell-in-Cell Invasion During Human Embryo Implantation |
||
4:45 p.m. - 5:00 p.m. |
O-101: A Single-Cell RNA-Seq Survey of Mouse Implantation Site Mapping the Contribution of Maternal Exogenous Bone Marrow Cells to Decidual Immune Landscape |
||
5:00 p.m. - 5:15 p.m. |
O-102: The Functional Requirement for PGRMC Proteins in Uterine Decidualization and Their Role in Lipid Metabolism and RNA Biology |
||
5:15 p.m. - 5:30 p.m. |
O-103: Interleukin-1β Induces and Accelerates Human Endometrial Stromal Cell Senescence and Impairs Decidualization via the c-Jun N-Terminal Kinase Pathway |
||
Placenta II Moderators: |
Meeting Room 11 |
||
4:00 p.m. - 4:15 p.m. |
O-104: The Effects of Trophoblast Invasion on the Maternal Cells in the Decidua of Early Pregnancy |
||
4:15 p.m. - 4:30 p.m. |
O-105: Macrophages Are Essential Regulators of Uterine Vascular Adaptation during Early Pregnancy in Mice |
||
4:30 p.m. - 4:45 p.m. |
O-106: Activin and FSTL3 Dynamics in Hemochorial Placentation |
||
4:45 p.m. - 5:00 p.m. |
O-107: Trophoblast-Specific Overexpression of Adiponectin Receptor 2 Inhibits Placental Mitochondrial Respiration in Mice |
||
5:00 p.m. - 5:15 p.m. |
O-108: Assessing Placental Health via Mid-Pregnancy Maternal Serum in Congenital Heart Defects |
||
5:15 p.m. - 5:30 p.m. |
O-109: Three-Dimensional Human Trophoblast Stem Cell Model Recapitulating Human Trophoblast Development during Pregnancy |
||
Reproductive Endocrinology and Infertility II Moderators: |
Meeting Room 12 |
||
4:00 p.m. - 4:15 p.m. |
O-110: Human Cathelicidin Peptide LL37 Enhances Efficacy of Mesenchymal Stem Cell-Derived Extracellular Vesicles as a Novel Treatment Approach for Polycystic Ovary Syndrome |
||
4:15 p.m. - 4:30 p.m. |
O-111: Cardiovascular Events Associated with PCOS Diagnosis in Longitudinal Cohort |
||
4:30 p.m. - 4:45 p.m. |
O-112: Single-Cell RNA Sequencing Reveals Mechanisms of Ovarian Preservation by AMH During Chemotherapy |
||
4:45 p.m. - 5:30 p.m. |
O-113: Chemotherapy Induced Pro-Apoptotic Extracellular Vesicles Transferring Caspase-8 in the Prepubertal Testis - Mechanistic Insights into Onco-Fertility Preservation in Pre-Pubertal Boys |
||
5:00 p.m. - 5:15 p.m. |
O-114: B Cells Are Regulators of Menopause-Associated Weight Gain, Glucose Metabolism and Adipose Tissue Dysfunction Mainly through E2/ERa Signaling |
||
5:15 p.m. - 5:30 p.m. |
O-115: Novel Pro-Regenerative Biomaterial for Combating Genitourinary Syndrome of Menopause |
||
Clinical and Translational Perinatology II Moderators: |
Meeting Room 13 |
||
4:00 p.m. - 4:15 p.m. |
O-116: The Role of Vaccination in Maternal Fetal Dyads in SARS-CoV-2 Antibody Transfer |
||
4:15 p.m. - 4:30 p.m. |
O-117:The Fetal Liver-Brain Axis: Zika Virus Infection Induces a Type I Interferon/Cytokine Response in Fetal Liver That Correlates with Brain Injury |
||
4:30 p.m. - 4:45 p.m. |
O-118: Neonatal Events and Childhood Respiratory Impairment |
||
4:45 p.m. - 5:00 p.m. |
O-119: Administration of Proteins Secreted by the Placenta Markedly Improves Outcomes in Premature Guinea Pigs |
||
5:00 p.m. - 5:15 p.m. |
O-120: Rytvela Prevents Preterm Birth and Neonatal Tissue Injury When Administered After the Onset of Preterm Labor While the Tocolytic Agent Nifedipine is Ineffective |
||
5:15 p.m. - 5:30 p.m. |
O-155: Tourniquet, Uterine Inversion, and Placental Dissection (TURIP) Procedure as a Novel Hemostatic Technique to Preserve Fertility for Placenta Accreta Spectrum Disorders without Placenta Previa Masafumi Nii, Yuya Tamaishi, Sho Takakura, Shoichi Magawa, Shinatro Maki, Kuniaki Toriyabe, Tomoaki Ikeda |
||
5:45 p.m. - 7:00 p.m. |
Presidential Address and Awards Ceremony |
Ballroom BC |
|
8:30 p.m. - 11:00 p.m. |
The Featles Canadian Tour |
Ballroom BC |
Saturday, March 16, 2024
7:00 a.m. - 1:00 p.m. |
Registration |
Lobby |
|
7:30 a.m. - 8:15 a.m. |
SRI Member Business Meeting |
Ballroom BC |
|
8:20 a.m. - 8:30 a.m. |
Welcome & Announcements |
Ballroom BC |
|
8:30 a.m. - 9:20 a.m. |
Ballroom BC |
||
9:30 a.m. - 11:30 a.m. |
Poster Session III |
Exhibit Hall B Convention Level - East |
|
11:30 a.m. - 1:00 p.m. |
Concurrent Oral Presentations IV |
||
Fetus II Moderators: |
Meeting Room 1 |
||
11:30 a.m. - 11:45 a.m. |
O-121: Maternal Obesity in Pregnancy Improves Fetal Responses to Maternal Hypotension in an Ovine Model |
||
11:45 a.m. - 12:00 p.m. |
O-122: Fetal Sheep Brain DHA Content is Preserved in Fetal Growth Restriction in Spite of Lower Maternal and Fetal Plasma DHA Concentrations |
||
12:00 p.m. - 12:15 p.m. |
O-123: Support on a Pumped Artificial Placenta Circuit Increases Cardiac Energy Demand in a Fetal Pig Model |
||
12:15 p.m. - 12:30 p.m. |
O-124: In Utero Delta-9-Tetrahydrocannabinol Exposure Adversely Affects Offspring Lung Development and Function |
||
12:30 p.m. - 12:45 p.m. |
O-125: Acute Fetal Hyperglucagonemia Increases Hepatic Expression of Genes Regulating Amino Acid Catabolism and Decreases Fetal Amino Acid Concentrations |
||
12:45 p.m. - 1:00 p.m. |
O-126: A Novel Device to Detect Fetal Asphyxia in Labour |
||
Gynecology III Moderators: |
Meeting Room 2/3 |
||
11:30 a.m. - 11:45 a.m. |
O-127: Pilot Data from the First Double-Blind Placebo-Controlled Vaginal Microbiota Transplantation Trial |
||
11:45 a.m. - 12:00 p.m. |
O-128: Extracellular Vesicles from Cervicovaginal Microbes Induced Immune Responses in Endometrial Cells |
||
12:00 p.m. - 12:15 p.m. |
O-129: Chlamydia and Gonorrhea Infection in an Endocervix Microphysiologic Model |
||
12:15 p.m. - 12:30 p.m. |
O-130: Human Vaginal Epithelial Stem Cells Are Negatively Impacted by Chemotherapy |
||
12:30 p.m. - 12:45 p.m. |
O-131: Novel Non-Invasive MRI Biomarkers of Interstitial Cystitis/Bladder Pain Syndrome |
||
12:45 p.m. - 1:00 p.m. |
O-159: Thymic Stromal Lymphopoietin Contributes to Endometriotic Lesion Proliferation and Disease-Associated Inflammation Stanimira Aleksieva, Danielle Sisnett, Katherine Zutautas, Harshavardhan Lingegowda, Alison McCallion, Chandrakant Tayade |
||
Placenta III Moderators: |
Meeting Room 8/15 |
||
11:30 a.m. - 11:45 a.m. |
O-132: Disrupted Collagen Architecture at the Previous Cesarean Scar is a Defining Pathology of Placenta Accreta Spectrum-Stop Blaming the Placenta |
||
11:45 a.m. - 12:00 p.m. |
O-133: Role of CEBPB in Early Events of Extravillous Trophoblast Cell Differentiation |
||
12:00 p.m. - 12:15 p.m. |
O-134: Race Differences in Energy Metabolism and Inflammatory Status of Mid-Gestation Human Placenta |
||
12:15 p.m. - 12:30 p.m. |
O-135: Impact of Placental SLC2A3 RNA Interference throughout Gestation |
||
12:30 p.m. - 12:45 p.m. |
O-136: Characterization of Human Cytotrophoblast Cell Population Dynamics throughout Pregnancy |
||
12:45 p.m. - 1:00 p.m. |
O-137: Toxoplasma gondii Polarizes Placental Trophoblast Differentiation Away from an Infection-Resistant Canonical Cell Lineage |
||
Reproductive Biology III Moderators: |
Meeting Room 11 |
||
11:30 a.m. - 11:45 a.m. |
O-138: Human Umbilical Cord Platelet-Rich Plasma: Metabolomic, Proteomic, and Wound Healing Studies in Endometrial Stem Cells |
||
11:45 a.m. - 12:00 p.m. |
O-139: Ovarian-Specific Extracellular Vesicles: A Novel Approach for Treating Premature Ovarian Insufficiency |
||
12:00 p.m. - 12:15 p.m. |
O-160: The Impact of Glucocorticoids on miRNA in the Epididymis of Adult Male Guinea Pigs |
||
12:15 p.m. - 12:30 p.m. |
O-140: Multi-Omics Profiling Reveals Regional Variations in the Healthy Fallopian Tube: A Comprehensive Analysis |
||
12:30 p.m. - 12:45 p.m. |
O-141: Serial Intravascular Labeling Unravels Trafficking Patterns of Decidual Lymphocytes in the Non-Human Primate |
||
12:45 p.m. - 1:00 p.m. |
O-142: Overexpression of Endometrial Epithelial 60S Acidic Ribosomal Protein P1 Induces Histopathologic Features and Transcriptome Profiles Consistent with Endometrial Cancer |
||
Preeclampsia II Moderators: |
Meeting Room 12 |
||
11:30 a.m. - 11:45 a.m. |
O-143: Activin A Persists in Maternal Serum in the Postpartum Period Suggesting an Active Role in Persistent Hypertension Following a HDP |
||
11:45 a.m. - 12:00 p.m. |
O-144: Alternative Activation of Macrophages Driven by Aberrantly Decidualised Endometrial Stromal Fibroblasts May Be a Pathogenic Process during Placentation in Pre-Eclampsia |
||
12:00 p.m. - 12:15 p.m. |
O-145: Circulating Inflammatory Profile in Early- and Late-Onset Preeclampsia: Contribution to Endothelial Activation |
||
12:15 p.m. - 12:30 p.m. |
O-146: First Trimester Vaginal Microbes and Immune Factors Predict Severe Preeclampsia |
||
12:30 p.m. - 12:45 p.m. |
O-147: Persistence of Circulating Cardiovascular Biomarkers Years Following a Hypertensive Disorder of Pregnancy |
||
12:45 p.m. - 1:00 p.m. |
O-148: Low Circulating SPINT1 at 36 Weeks Gestation Strongly Predicts Fetal Growth Restriction and Adverse Neonatal Outcomes |
||
Benign & Malignant Tumors Moderators: |
Meeting Room 13 |
||
11:30 a.m. - 11:45 a.m. |
O-149: The Pathological Reprogramming of N6-methyladenosine Epitranscriptome in Human Uterine Fibroids |
||
11:45 a.m. - 12:00 p.m. |
O-150: Bone Mineral Density After 48 Months of Elagolix + Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids |
||
12:00 p.m. - 12:15 p.m. |
O-151: Improving the Diagnostic Accuracy of an Ovarian Cancer Triage Test Using a Joint miRNA-Protein Model |
||
12:15 p.m. - 12:30 p.m. |
O-152: NGS Compartment Analysis Revealed Uniformity within the Stroma and Type-Specific Differences in the Epithelium of Endometriosis-Associated and High-Grade Serous Ovarian Carcinomas |
||
12:30 p.m. - 12:45 p.m. |
O-153: Obesity and the PTEN Mutant Endometrium |
||
12:45 p.m. - 1:00 p.m. |
O-154: SERINC2 Promotes the Occurrence and Development of Cervical Cancer via Competing for Serine to Drive T Cells Exhaustion |
||
1:15 p.m. - 2:45 p.m. |
Hot Topics & Awards Ceremony Moderators: |
East Ballroom BC |
|
1:15 p.m. - 1:30 p.m. |
O-161: Placental Extracellular Vesicles Modifies Future Cardiovascular Disease Development in Rodents |
||
1:30 p.m. - 1:45 p.m. |
O-162: Characterisation of Small Extracellular Vesicles in Endometriosis Patients: Cellular Origins and Macrophage Modulation within the Peritoneal Microenvironment |
||
1:45 p.m. - 2:45 p.m. |
Awards Ceremony
|